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Abstract
Tissue-engineered constructs are promising to overcome shortage of organ donors and to reconstruct at least parts
of injured or diseased tissues or organs. However, oxygen and nutrient supply are limiting factors in many tissues,
especially after implantation into the host. Therefore, the development of a vascular system prior to implantation
appears crucial. To develop a functional vascular system, different cell types that interact with each other need to
be co-cultured to simulate a physiological environment in vitro. This review provides an overview and a comparison of
the current knowledge of co-cultures of human endothelial cells (ECs) with human adipose tissue-derived stem/
stromal cells (ASCs) or bone marrow-mesenchymal stem cells (BMSCs) in three dimensional (3D) hydrogel matrices.
Mesenchymal stem cells (MSCs), BMSCs or ASCs, have been shown to enhance vascular tube formation of ECs and to
provide a stabilizing function in addition to growth factor delivery and permeability control for ECs. Although
phenotypically similar, MSCs from different tissues promote tubulogenesis through distinct mechanisms. In this report,
we describe differences and similarities regarding molecular interactions in order to investigate which of these two cell
types displays more favorable characteristics to be used in clinical applications. Our comparative study shows that ASCs
as well as BMSCs are both promising cell types to induce vascularization with ECs in vitro and consequently are
promising candidates to support in vivo vascularization.
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Introduction
One of the major challenges in tissue engineering today
is the realization of an integrated vascular network to
provide adequate blood supply for living cells in tissue
constructs. Limited by oxygen diffusion only, tissue-
engineered products for skin- and cartilage-regeneration
are already used in clinics [1]. However, organs with a
more complex structure need a vascular system which
integrates with the host vascular system to provide suffi-
cient oxygen and nutrient supply to the cells [2].
To overcome the problem of missing ingrowth of host
vessels into the construct, different approaches have
been investigated [3]. Integration of signaling molecules
in scaffolds to stimulate the growth of blood vessels
from the host after in vivo implantation is a currently
pursued strategy. Another method represents the in
vitro generation of pre-vascularized tissues that will be
connected to the host upon implantation. In the latter
case, critical parameters for vascularization are the
choice of cells, in addition to the culture medium, ap-
propriate matrix, and cell seeding parameters [4–8].
Physiological microvasculature compromises endothe-
lial cells (ECs) and in addition supportive cells, termed
mural cells, to ensure controlled permeability, contrac-
tion, and stability and to supply growth factors. Mesen-
chymal stem cells (MSCs), a population of adult stem
cells, develop into mural cells in vitro when co-cultured
with ECs [9]. MSCs present a heterogeneous population
of cells found in various tissues. Adipose tissue-derived
stem/stromal cells (ASCs) [10] and bone marrow derived
stem cells (BMSCs) provide autologous sources for adult
stem cells. While both cell types are phenotypically very
similar, they promote vascular tube formation via
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distinct molecular interactions [11]. These tube forma-
tions have been shown being capable of anastomosing
with the host vascular system when implanted in vivo,
independent of the MSC type used to induce EC out-
growth [12–15]. In this review, we focus on the differ-
ences and similarities in molecular interactions between
human ECs on one side and on the other side human
ASCs compared to human BMSCs in microvascular tube
formation. Current knowledge is summarized and ques-
tions and discrepancies are critically discussed in order
to investigate which of both types of MSCs might be
more favorable in future clinical applications.
Endothelial cells (ECs) for vascularization
The endothelium forms the inner cellular lining of blood
and lymphatic vessels. Consequently, vascular ECs play a
critical role in many physiological processes, including
the control of vasomotor tone, blood cell trafficking, the
maintenance of blood fluidity, hemostatic balance, per-
meability, angiogenesis, and both innate and adaptive
immunity. They are also involved in vasculogenesis and
angiogenesis during wound healing and repair and are
therefore very important for vascularization strategies in
tissue [6, 16–18]. Because of the remarkable heterogen-
eity of ECs in structure and function, defining the endo-
thelium is difficult. Each vascular bed has its own
specialized ECs which demonstrate unique structural
(e.g., presence of Weibel-Palade bodies and morphology
[19]) and functional properties, developmental pro-
grams, and roles in pathophysiology. Therefore, even
after several attempts, there is a lack of a uniform cellu-
lar definition or functional characterization for this cell
type [16–18]. Characteristic EC markers include CD31,
vascular endothelial—cadherin (VE-cadherin), von Will-
ebrand factor (vWF), vascular endothelial growth factor
receptor 2 (VEGFR-2), thrombomodulin, and endoglin
[20–25]. The co-existence of these markers on ECs is
crucial in the definition of “EC” because most of these
markers are not exclusively expressed on ECs. For pre-
vascularizing strategies, ECs from different sources have
been described. Human umbilical vein endothelial cells
(HUVECs) are the most prominent endothelial cell type
used as representatives of ECs in co-culture systems for
vascularization because they are easy to isolate. While
HUVECs are a population of ECs present in large blood
vessels, ECs isolated from dermal blood and lymphatic
vessels reflect molecular and morphological characteris-
tics of the microcapillary bed. These microvascular ECs
are found in the dermis of juvenile foreskin and different
locations in adult skin, which are predominantly in-
volved in tumor angiogenesis, wound healing, and in-
flammation and are named human dermal microvascular
endothelial cells (HDMVECs) [26]. However, HUVECs
and HDMVECs cannot be generally harvested from
every individual and therefore do not provide an autolo-
gous cell source. A widely approved concept involves the
existence of endothelial progenitor cells (EPCs) which
were first described by Asahara et al. [27]. EPCs are
human blood-circulating cells which are defined to be
positive for CD133, CD34, and VEGFR-2. They were re-
ported to differentiate ex vivo in cells with endothelial-
like characteristics, including the formation of vessel-like
structures under defined conditions and of cobblestone
patterns when the population is growing to confluence
in culture. Therefore, EPCs are primarily described by
their cell-surface antigens and not like other progenitor
cells by their ability to proliferate and to give rise to
functional progeny [2, 6]. About 0.01 % of peripheral
blood mononuclear cells (PBMNCs) are considered to
be EPCs [28]. Today, there is no uniform clonogenic
definition of EPCs or an experimental method to distin-
guish between different EPC subgroups [2, 6]. “Early”
EPCs have been described as cells derived from bone
marrow and expressing surface markers such as CD14,
CD45, and CD133, which are shared with hematopoietic
stem cell populations. They are thought to act in a para-
crine manner, providing angiogenic factors [2, 29]. In
contrast, “late” EPCs, also called outgrowth endothelial
cells (OECs), appear much later in culture and exhibit
characteristics which are reported as “typically endothe-
lial” [2], meaning the expression of vWF, CD31, VE-
cadherin, and connexin (Cx)43 and Cx45. They show
high proliferative potential and are furthermore incorpo-
rated into resident vasculature [2, 29].
Mesenchymal stem cells (MSCs) as source for
vasculogenic growth factors
MSCs represent a resident population of stem cells in
many adult tissues. Adult stem cells are undifferentiated
cells capable of differentiation into specialized cell types
of various tissues and avoid ethical concerns that arise
with embryonic stem cells [30]. Today, there are many
different approaches to characterize MSCs. The “Mesen-
chymal and Tissue Stem Cell Committee of the Inter-
national Society for Cellular Therapy” proposed minimal
criteria to define human MSCs. These include the fol-
lowing: (1) plastic-adherence of MSCs when maintained
in standard culture conditions; (2) positive display for
endoglin, CD73, and CD90 and negative for CD45,
CD34, CD14 or CD11, CD97alpha or CD19, and HLA-
DR surface molecules; and (3) differentiation potential
into osteoblasts, adipocytes, and chondroblasts in vitro
[11]. MSCs have the ability to differentiate into mural
cells (pericytes or smooth muscle cells) in vitro. The dif-
ferentiation occurs due to heterocellular communication
via gap junctions of ECs and MSCs [31]. Mural cells
make up the surrounding layer of blood vessels and are
therefore crucial for conferring support and stabilization
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of these vessels [32]. There is evidence that MSCs ex-
press angiogenic factors like vascular endothelial growth
factor (VEGF), fibroblast growth factor-2 (FGF-2), angio-
poietin 1 (Ang-1), and epidermal growth factors (EGF)
[33, 34]. Within the human body, the most common
source for MSCs used in research today is bone marrow
(BM). MSCs derived from bone marrow are referring to a
heterogeneous cell population named BMSCs or just
“MSCs”. However, BM aspiration is an invasive procedure
and therefore other sources of MSCs have been under in-
vestigation. Another autologous source of MSCs beside
BM is adipose tissue. Even small amounts of human sub-
cutaneous adipose tissue contain enough multipotent
MSCs to be cultured and expanded in vitro. Therefore,
autologous cells can be harvested with minimal invasive-
ness, which makes fat a very attractive source for MSCs
[35]. Remarkable heterogeneity of human ASCs has been
reported due to different harvest, characterization, and
culture techniques next to donor variations [36]. Stan-
dardized protocols which were proven to be reproducible
would meet this problem have been published [10].
Co-culture of endothelial cells (ECs) with bone marrow-
mesenchymal stem cells (MSCs)
Molecular interactions in co-cultures of BMSCs and ECs
are of great interest because BMSCs promote the forma-
tion of vessel-like structures in three dimensional (3D)
matrixes (Fig. 1), [9, 37–39] which is supported by the
fact that HUVECs cultured without another cell type did
not form any organized structures. After 14 days of co-
culturing HUVECs with BMSCs, the expression of alpha
smooth muscle actin (α-SMA) in BMSCs increased com-
pared to expression before co-culture and surrounded
EC cord-like structures. A multiplex chemiluminescent
ELISA was performed by Verseijden et al. after 14 days
of BMSC monoculture to analyze which angiogenic fac-
tors were increased in BMSC-conditioned medium com-
pared to unconditioned medium or HUVEC-conditioned
medium [9]. Results showed significantly higher amounts
of hepatocyte growth factor (HGF), tissue inhibitor of me-
talloproteinase 1, and tissue inhibitor of metalloproteinase
2 (TIMP1 and TIMP2) in co-culture compared to mono-
culture. These factors are known also to regulate vessel
formation. Additionally, HGF stimulates EC proliferation
and induces vessel formation [40]. On the other hand, ex-
periments using different concentrations of HGF failed to
induce HUVEC outgrowth in monocultures. Regarding
the high amount of TIMPs, further investigations have
been performed because TIMPs had also been reported to
inhibit the activity of matrix metalloproteinases (MMPs)
[41]. Because of the high concentration of serum in the
growth media, which is known to have a high MMP con-
centration itself, it was not possible to discriminate the
amount of MMPs secreted specifically by BMSCs. Never-
theless, much of the fibrin was removed within the fibrin
matrix, suggesting that MMPs or other factors were
secreted in sufficient amount to degrade the fibrin.
Despite the findings of angiogenesis related factors in
BMSC-conditioned medium, HUVECs treated with this
medium showed no positive effect regarding outgrowth or
organization. The fact that BMSCs co-cultured with
HUVECs induced outgrowth showed that HUVEC out-
growth and organization into vessel-like structures is not
merely achieved by secreted factors. This suggests that
direct cell-cell contact and reciprocal signaling may play
an important role for ECs to form pre-vascular-like struc-
tures [9]. To investigate the angiogenesis promoting and
vessel stabilization functions of BMSCs on ECs, BMSCs
have been co-cultured with EPCs or HUVECs in a 3D
polyurethane scaffold [37]. Luminal tubular structures
were detected after 7 days of culture, which were not only
positive for endothelial cell markers CD31 and vWF, but
also for CD146, expressed by pericytes but not ECs. Se-
quential sectioning of scaffolds revealed areas positive for
CD146, neuron-glial antigen 2 (NG2), and α-SMA, which
were tightly associated with tubular structures. The
Fig. 1 Example of how BMSCs support EC network formation in a fibrin matrix. a Fluorescent image of a capillary network on day 7. Thresholds
were set before applying the Angiogenesis Tube Formation Application Module in Metamorph imaging software. b To visualize networks, the
filament tracing function was used using Imaris. ECs are depicted in blue and BMSCs in red [39]
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combination of CD146, NG2, and α-SMA confirmed the
pericyte phenotype. Furthermore, neither EPCs nor
BMSCs cultured alone could form pre-vascular structures
which showed the major role of BMSCs in promoting
EPCs to differentiate into a mature network. These experi-
ments further indicated that both cell types influence each
other in terms of differentiation. BMSCs did prevent a de-
crease in number of HUVECs and EPCs that was ob-
served in these cells after 7 days in 3D culture when
cultured alone. Interestingly, the study revealed that
microvessel-like structures only developed when dexa-
methasone was added to culture medium. Dexamethasone
is known to induce an osteogenic phenotype in BMSCs,
which will alter growth factor and extracellular matrix
(ECM) protein release by these cells. However, the under-
lying molecular interactions and alterations during this
development remained unclear [37]. Another study inves-
tigated the expression of different angiogenic factors
(FGF-2, transforming growth factor beta 1 [ TGFB1] and
vascular endothelial growth factor A [ VEGFA]) and
osteogenic marker genes (collagen type 1 alpha 1
[COL1A1], integrin-binding sialoprotein [IBSP], and tran-
scription factor 7 [SP7]) of BMSCs via qPCR after 7 days
in different culture media. While cells cultured in osteo-
genic medium supplemented with dexamethasone showed
enhanced expression of osteogenic marker genes, they
showed a significant lower expression of angiogenic genes
compared to BMSCs cultured with growth medium free
of dexamethasone. These data were further supplemented
by an experimental setup using endothelial colony form-
ing cells (ECFCs) and BMSC-conditioned media. While
BMSC-conditioned growth medium increased angiogenic
stimulation, the addition of dexamethasone showed min-
imal angiogenic potential [42]. Furthermore, not only cul-
ture medium but also matrix composition and cell-cell
ratios altered the potential of ECs co-cultured with
BMSCs to form tubular networks. Using a collagen Type I
3D matrix for co-culturing HUVECs with BMSCs resulted
in a decreased vasculogenic response compared to fibrin-
containing matrixes [38]. On the other hand, the ratio be-
tween ECs to BMSCs was not a strong modulator of the
network development. However, a high EC:BMSC ratio
(5:1) showed unstable vessel formation compared to lower
ratios [38]. BMSCs did not only promote outgrowth of
ECs but also showed a stabilizing function of new vessels,
by acting as mural cells and controlling permeability. In
contrast to a 3D co-culture model of HUVECs with fibro-
blasts, HUVECs co-cultured with BMSCs in the same 3D
model showed a higher control in permeability due to a
higher number of cell-cell adherent junctions between
ECs. Vessels supported by BMSCs also showed slower
promotion of vessel formation, leading to a higher rate of
branches and therefore shorter vessels, which are features
indicating physiological vessel growth [43]. While BMSCs
provided angiogenic factors and stabilized vascular net-
works in vitro, they could also act as osteogenic progeni-
tors, forming mineralized bone matrix, thus providing an
approach for bone tissue engineering (Fig. 2). Temporal
variation of the medium can induce not only the develop-
ment of vascular networks but also osteogenic differenti-
ation in one and the same co-culture system of HUVECs
and BMSCs in vitro, suggesting that BMSCs act as peri-
cytes; the BMSCs even maintained their ability to undergo
osteogenesis [44]. To analyze the intercellular communi-
cation between BMSCs and ECs, global gene expression
was studied. BMSCs and HUVECs were co-cultured for 5
and 15 days to observe relative alterations to the BMSCs
previous to co-culture with HUVECs. In this direct cul-
ture model, genes related to angiogenesis (vWF, CD31,
VE-cadherin, angiopoietin-related protein 4, and CD34)
were upregulated. Additionally, the results indicated that
the effects of ECs on the BMSC genotype were more
prominent after 5 days of co-culture than after 15 days.
Among the most upregulated genes were also genes asso-
ciated with cell adhesion (e.g., CD31 and CD34) and cell-
ECM communication (e.g., CD93, cadherin 5 [CDH5],
Fig. 2 BMSCs supporting vascularization and forming mineralized bone matrix in a single co-culture system with HUVECs. When cultured in
medium supported with angiogenic factors, BMSCs (beige cells) support ECs networks (red) as pericytes. When the co-culture system is supported
with osteogenic factors, BMSCs undergo osteogenic differentiation (blue cells) and produce mineralized bone matrix (beige lines) [44]
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and vWF) suggesting that these processes are also import-
ant for crosstalk between BMSCs and ECs. The informa-
tion upon which genes in BMSCs are upregulated when
co-cultured with ECs provided insights about the bidirec-
tional gene regulation of angiogenesis and osteogenesis
[45]. Another important regulator of vessel formation is
α6β1 integrin, a laminin receptor present on BMSCs. To
evaluate the impact of this receptor on EC outgrowth,
HUVECs and BMSCs were co-cultured in a 3D fibrin
matrix and RNA interference was used to knock down the
β6-integrin subunit of the laminin receptor, resulting in
80 % shorter vascular networks in terms of total length
compared to HUVECs co-cultured with wild type BMSCs.
Furthermore, laminin expression was reduced as well as
proliferation of BMSCs in co-cultures in which the RNA
interference was induced. Co-cultures of ECs with BMSCs
showed no expression of α-SMA in contrast to the control
group. This results lead to the suggestion that BMSCs
might need the α6β1 to differentiate into pericytes and to
induce EC capillary tube formation [46]. Platelet-derived
growth factor receptor (PDGFR) is another molecule
which showed to be potentially important for angiogen-
esis. It has been tested if PDGFR signaling influences the
migration of BMSCs towards ECs [47]. A Transwell mi-
gration assay revealed that HUVECs significantly in-
creased the number of BMSCs migrating across the
transwell membrane compared to control medium only.
To test whether PDGFR plays a role in this mechanism,
imatinib mesylate, an inhibitor of PDGFR, was added to
the cell culture medium. This resulted in less migration of
BMSCs towards HUVECs in a dose-dependent manner,
confirming that PDGFR is at least partly responsible for
migration of BMSCs towards ECs [48]. Regarding the for-
mation of tubular networks, studies have been undertaken
using a 3D fibrin model in which BMSCs were co-cultured
with ECs to investigate the molecular mechanisms of ECM
degradation. Results showed that co-culturing with BMSCs
lead to an increase in the transcript expression of extracel-
lular proteases in HUVECs. After 3 days of co-culture, ca-
pillary structures had formed and RT-PCR revealed
enhanced expression of MMPs in ECs. A broad spectrum
of MMP inhibitors blocked the capillary network forma-
tion in the HUVEC–BMSC co-culture, in contrast to co-
cultures of HUVEC with fibroblasts where pre-vascular
structures could be observed even when these inhibitors
had been added. This indicated that different cells used in
co-cultures with ECs also induce different proteolytic en-
zymes [39]. Based on these findings, further studies in a fi-
brin based co-culture model were done exploring the
specific proteinase dependency in BMSC-mediated angio-
genesis [49]. First, the importance of soluble MMPs
(MMP-2 and MMP-9) was investigated. Retroviral shRNAs
were used to attenuate their expression in ECs. These ECs
were then co-cultured with BMSCs, which resulted in
unaffected vessel sprouting, compared to co-cultures with
mock-infected ECs. As a control, an MMP inhibitor
(GM6001) was used, which resulted in drastic inhibition of
vessel sprouting. Furthermore, knockdown of membrane
type-1 matrix metalloproteinase (MT1-MMP) lead to lim-
ited vessel formation in HUVECs. The short vessel-like
structures displayed abnormally enlarged lumens. These
results suggest that remodeling of the ECM, which is im-
portant for invasion of pre-vascular structures, involves
MMPs [49].
Co-cultures of endothelial cells (ECs) with adipose stem
cells (ASCs)
Molecular interactions between ASCs and ECs are of
interest because there is evidence that ASCs co-cultured
with ECs in vitro support the formation of pre-vascular
structures and allow network formation (Fig. 3) [9, 33,
43, 50–52]. ASCs participating in the network expressed
abundantly α-SMA and CD34 and the cells expressing
these molecules surrounded the ECs, suggesting a stabil-
izing role [9]. Recent data on the molecular mechanisms
by which ASCs support angiogenesis and provide vascu-
logenic functions for ECs are often difficult to interpret
and compare due to a lack of standardization and data
on factors like media composition, cell ratios, matrix
and seeding logistics. One aspect concerning the inter-
action of ECs and ASCs is to what extent the outgrowth
of ECs and the network formation depends on the se-
creted factors compared to cell-cell interactions and
Fig. 3 HUVECs (green) form pre-vascular structures in co-culture with
ASCs (red) in fibrin after 4 weeks. HUVECs were transfected with
green fluorescence protein to make vascular structures visible under
a fluorescence microscope. A staining against NG2 was performed,
showing that only ASCs express this surface marker protein. Additionally,
it shows that ASCs surrounded the cord-like structures formed by
HUVECs(shown by arrows) [33]
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reciprocal signaling. Approaches to address the molecu-
lar interactions between these two cell types include dir-
ect co-culture or culturing ECs in MSC conditioned
medium. Different groups investigated the influence of
the supernatants of ASCs on EC outgrowth and mature
vessel formation. ASC-conditioned medium had a posi-
tive effect on HUVECs and OECs outgrowth [9, 33].
However, the ASC-conditioned medium did not lead to
fully branched networks, which indicates that direct cell-
cell contact or at least proximity of ASCs with ECs is ne-
cessary for tube formation [9, 33, 50]. This assumption
was further supported by an experimental setup in
which ASCs were seeded on microcarrier beads to retain
them to specific sites of a fibrin matrix. There, only ECs
near the ASC-coated beads started to form networks
[33, 35]. However, not only the EC phenotype changed
in co-culture but also the phenotype of the ASCs. Some
findings suggested that co-cultured ASCs differentiate
towards the smooth muscle lineage. This suggestion was
due to the upregulation of α-SMA in cells that surrounded
the endothelial cord-like structures in co-cultures eventu-
ally stabilizing them and thus representing physiological
microvasculature [9, 50]. In addition, it was reported that
ASCs express NG2 in regions of bifurcation presence in
co-culture with ECs, which indicates the development of
pericyte characteristics [33, 53]. These findings substanti-
ate the stabilizing function of ASCs. To investigate the
functionality of vessels supported by different mural cells,
an inverse permeability model using a dextran (65 kDa)
was applied [43] which is one possibility to examine vessel
permeability next to in vivo approaches using fluores-
cently conjugated lectins [15]. Dextran was added to the
bulk tissue to reveal incomplete cell-cell junctions by en-
tering immature vessels lumens. Two weeks after start of
the co-culture, less dextran was inside the lumen than
after 3 days, likely because of mural cells constructs,
which made direct contact with the capillary sprouts.
Comparing fibroblasts with ASCs used as supporting
mural cells in co-culture with HUVEC, ASCs seemed to
mimic the physiology of healthy vasculature better than fi-
broblasts as evidenced by more controlled permeability,
which might have been a result of an increase in EC-EC
adherens junctions [43]. The molecular interactions re-
sponsible for this development remain to be clarified. An-
other aspect concerning angiogenesis is the proteolysis of
the ECM, which depends on the cell type co-cultured with
ECs. Co-culture models of HUVECs with ASCs with in-
hibition of different protease-families showed that the
morphogenesis of blood vessels relied on the plasmin fam-
ily of proteases for EC elongation and invasion. MMPs
regulated these parameters to a lesser extent. However,
luminal diameter and regulation and possibly vessel
stabilization was dependent on these proteinases. Co-
culturing HUVECs with ASCs resulted in a promotion of
using the plasmin system for proteolysis in HUVECs,
while the level of MMPs was unaffected [51]. These data
combined with the upregulation of the proangiogenic fac-
tors HGF and tumor necrosis factor alpha (TNF-α) within
these co-culture systems demonstrated the similarities of
molecular communication between co-cultured ASCs or
fibroblasts and ECs [51]. On the other hand, a study using
OECs instead of HUVECs for a co-culture model with
ASCs in a fibrin matrix reported the expression of MMP-
14 on these ECs [52]. The results were supported by the
fact that robust vessels developed even when a low con-
centration of aprotinin was added to the medium, which
is known to prevent premature fibrin degradation by the
plasmin system. According to these findings, OECs form
vascular networks supported by ASCs in a fibrin matrix.
Furthermore, OECs showed potential molecular differ-
ences in fibrin degradation compared to HUVECs [52]. In
a setting where co-cultures of ASCs with HUVECs in a fi-
brin clot were compared to co-cultures of ASCs with
OECs, OECs were reported to form a mature network
earlier than HUVEC, hinting that different ECs show dif-
ferent molecular interactions within co-cultures with
ASCs [33]. Another approach to investigate the molecular
interactions of ECs and ASCs in co-culture is the evalu-
ation of gene expression levels via RT-qPCR. Experiments
showed an increase in CD31 and VE-cadherin after 1 week
of co-culture. These molecules are known to be cellular
adhesion molecules which help cells in networks to attach
to each other. In addition, VEGFR-2, the main receptor
for VEGF and vWF, were also increased, in contrast to
platelet-derived growth (PDGF) factor and Tie-2. CD31,
VE-cadherin, VEGFR-2, and vWF are known to contribute
to the prevention of uncontrolled vessel growth. However,
PDGF and Tie-2 are mainly involved in vessel stabilization;
therefore, their expression levels might have increased after
several more weeks of co-culture [33]. An angiogenesis
protein array gave further insight into the molecular inter-
actions of ECs and ASCs in co-culture [33]. After 4 days of
culture, EC tube formation was already visible; therefore,
supernatants were collected on the fourth day and ana-
lyzed. Comparing the results of the assay of OEC mono-
cultures which were cultured with supernatant from ASC
monocultures to OEC-ASC co-cultures, the co-culture
showed more than two-fold increase of several proangio-
genic factors: platelet-derived endothelial cell growth factor
(PD-ECGF), FGF-2, MMP-9, Ang-2, and pentraxin-3. This
leads to the suggestion that a lack of these angiogenic pro-
teins might be the cause for impaired vessel formation.
However, some of these cytokines are known to work in
an agonist–antagonist interaction, hence further substanti-
ating that the co-culture of ECs with ASCs leads to physio-
logical, controlled vascular network formation [33].
Addressing the ECM production in co-culture systems of
ECs and ASCs, different ECM proteins are reported to be
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upregulated in co-culture. Collagen IV was not only in-
creased in co-culture but was restricted to the surface of
vessel forming cord-blood-derived ECs. Additionally, fibro-
nectin was expressed in higher concentrations and also its
extracellular accumulation in fibrillary form was higher.
Expression of perlecan I, a heparan sulfate proteoglycan,
was also increased in co-culture compared to ASC and EC
monoculture, showing an increased amount in proximity
to EC vessel structures. Laminin showed no increase but
accumulated near EC vascular structures, too. Collagen IV,
fibronectin, perlecan I, and laminin are components of the
basement membrane, which separate connective tissue
from endothelial cells and are therefore associated with
vessel formation [54]. According to these finding, cell-cell
contacts have an impact on ECM production and therefore
on vessel maturation [50].
Differences between bone marrow-mesenchymal stem
cells (MSCs) and adipose stem cells (ASCs) in co-culture
with endothelial cells (ECs)
Comparing the molecular interactions of ASCs and
BMSCs with ECs is difficult because while ECs are a ra-
ther homogenous population, adult stem cells provide
very heterogeneous populations. Therefore, not only the
results how ASCs influence ECs compared to BMSCs
differ, but in both cases, harvesting, culture methods,
and donor variations may additionally be a crucial factor.
Furthermore, different populations of ECs (e.g., HUVECs
and OECs) showed different reactions in co-culture sys-
tems with adult stem cells. Only few studies investigated
co-cultures of ECs with ASCs and BMSCs in the same
experimental setup to check for differences between
these two cell types. Nevertheless, investigations into the
molecular interactions of these cell types in co-culture
are crucial because both, ASCs and BMSCs, stimulate
ECs to form vessel-like structures in vitro. Furthermore,
both MSC types supported EC networks by expressing a
pericyte-like phenotype (expression of α-SMA and
NG2), which makes them very attractive for
vascularization techniques in tissue engineering [9].
ASCs and BMSCs are both more favorable than fibro-
blasts because they do mimic a more physiological vessel
growth [43]. Another similarity of ASCs and BMSCs is
the need of heterotypic cell-cell contacts or at least the
close cellular proximity with ECs to induce network for-
mation. While ASC supernatant has been reported to in-
duce at least outgrowth of ECs [9], BMSC-conditioned
medium showed no effect on ECs [33]. Furthermore, in-
vestigating the gene expression profile gives an oppor-
tunity to observe differences in intercellular
communication in ASCs compared to BMSCs. While
BMSCs represent the state of the art cell type of MSCs
in these co-culture systems, ASCs might be preferred
over BMSCs in future. ASCs can be harvested with a less
invasive technique and are in general present in higher
numbers in adipose tissue than BMSCs are in bone mar-
row [55]. Differences between BMSCs and ASCs in co-
culture with ECs are summarized in Table 1.
Functionality of engineered microvessels
with mesenchymal stem cells (MSCs) in vivo
Since analysis of the functionality of microvessel-like
structures in vitro is difficult to prove, different in vivo
models have been established. EPCs co-cultured with
BMSCs show formation of vascular structures in Matri-
gel as well as in type I collagen, fibrin, and PuraMatrix,
an engineered peptide hydrogel, 7 days after the ECM-
containing cells were injected subcutaneously in immuno-
deficient mice [14, 56]. Such structures could also be
Table 1 Differences between BMSCs and ASCs in co-culture with ECs
BMSCs ASCs
3D matrix used for
co-culture
Fibrin [9, 38, 39, 42, 43, 49], polyurethane [37],
type I collagen [38], fibrin + type I collagen in
different ratios [38]
Fibrin [9, 33, 43, 51, 52]
Pericytic marker α-SMA [9, 37, 46], NG2 [37], CD146 [37] α-SMA [9, 50], NG2 [33]
Paracrine factors HGF, TIMP1, TIMP2 [9] HGF, TNF-α [51], PD-ECGF, FGF-2, MMP-9,
Ang-2, pentraxin-3 [33], ECM proteins:
collagen IV, fibronectin [50]
Altered gene expression FGF-2 ↑, TGFB1 ↑, VEGFA ↑ [42], vWF ↑, CD31 ↑,
VE-cadherin ↑, angiopoietin-related protein 4 ↑,
CD34 ↑, CD93 ↑, CDH5 ↑ [45], MMPs ↑ [39]
CD31 ↑, VE-cadherin ↑, VEGFR-2 ↑, vWF ↑ [33]
Endothelial cell type HUVECs [9, 37–39, 43, 45, 46, 48, 49],EPCs [37],
ECFCs [42]




Yes (in contrast to fibroblasts) [39, 49] Yes [52], to a lesser extent as plasmin family
proteases [51]
BMSCs and ASCs have different effects on ECs and show altered behavior concerning pericytic marker expression, paracrine factors, gene expression, and
importance of MMPs for network formation. Furthermore, different matrices as well as different EC types were used to investigate effects of MSCs on ECs
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found after 2 weeks when a collagen/fibronectin matrix
containing EPC-ASC co-cultures was implanted [57].
Even 7 weeks after injection of Matrigel containing ECFC-
BMSC co-cultures in nude mice, durable neo-vessel
formation was found in Matrigel plugs [58]. A subset of
pre-vascular structures formed in in vitro cultured
spheroids containing HUVECs as well as ASCs was
able to anastomose with the host vascular system of
athymic male nude mice [13]. Moreover, co-cultures
of OECs and ASCs in fibrin resulted in a perfusable
microvascular network when implanted subcutane-
ously in a nude mouse model (Fig. 4). In most cases,
functionality has been verified by locating mouse red
blood cells inside vascular structures built by human
ECs or by injection of perfusion-indicating agents, for
example fluorescently labeled lectins.
Conclusion
To conclude, ECs and MSCs co-cultured in a 3D matrix
provide a promising approach for vascularization in tis-
sue engineering. ASCs and BMSCs are both promising
candidates for co-culture systems with ECs because they
can be harvested in adults and therefore provide an au-
tologous cell source. While all MSCs seem to have a very
similar phenotype, they do interact through different
molecular mechanisms with ECs. Co-cultures of BMSCs
with various cell types are better researched because
they are also used for bone regeneration models, and be-
cause there, vascularization remains one of the most
limiting factors. On the other hand, the advantage of
ASCs is reflected by a less invasive technique, and cells
are present in higher numbers. Therefore, it is important
to increase efforts whether ASCs or BMSCs provide
more promising features for vascularization techniques.
Further research in this field will hopefully shed more
light on the important signaling mechanisms involved in
these co-culture models.
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